Sonoma Pharmaceuticals Inc
(SNOA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,308 | -11,798 | -14,328 | 9,274 | -10,162 |
| Depreciation Amortization | 312 | 453 | 490 | 248 | 244 |
| Accounts receivable | -2,190 | -1,164 | 11 | -2 | -1,282 |
| Accounts payable and accrued liabilities | 336 | 5 | 9 | -58 | 429 |
| Other Working Capital | -1,197 | -1,266 | -1,752 | -293 | -1,662 |
| Other Operating Activity | 1,456 | 2,053 | 3,131 | -17,336 | 3,687 |
| Operating Cash Flow | $-4,591 | $-11,717 | $-12,439 | $-8,167 | $-8,746 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -206 | -100 | -187 | -394 | -345 |
| Net Acquisitions | 3,800 | N/A | N/A | 18,639 | N/A |
| Purchase Of Investment | 50 | -31 | -14 | -21 | -2 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 4,538 |
| Investing Cash Flow | $3,644 | $-131 | $-201 | $18,224 | $4,191 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -334 | -478 | -280 | -130 | -119 |
| Common Stock Issued | 1,376 | 5,970 | 1,020 | 98 | 6,158 |
| Other Financing Activity | -13 | 0 | 4,500 | 0 | 0 |
| Financing Cash Flow | $1,029 | $5,492 | $5,240 | $-32 | $6,039 |
| Exchange Rate Effect | -80 | -21 | 5 | -33 | -151 |
| Beginning Cash Position | 3,689 | 10,066 | 17,461 | 7,469 | 6,136 |
| End Cash Position | 3,691 | 3,689 | 10,066 | 17,461 | 7,469 |
| Net Cash Flow | $2 | $-6,377 | $-7,395 | $9,992 | $1,333 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,591 | -11,717 | -12,439 | -8,167 | -8,746 |
| Capital Expenditure | -206 | -100 | -187 | -394 | -345 |
| Free Cash Flow | -4,797 | -11,817 | -12,626 | -8,561 | -9,091 |